Skip to main content
All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q2 report for UCB, INC. on July 16, 2026, reporting $70,000 in lobbying income.

Lobbying for UCB, INC. · Biopharmaceutical company

All filings by THE NICKLES GROUP, LLC · Everything UCB, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 16, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
Georgia

Official filing document

 Lobbyists on this filing 1
  • MOLLY FROMM New on this filing
    Previously held: (continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Taxation/Internal Revenue Code

Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations.

Health Issues

Issues related to medication step therapy. S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.

Trade (domestic/foreign)

Issues related to tariffs.

Medicare/Medicaid

Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to access to home infusion. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.

 Bills named in this filing 4
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 591
    Defending American Jobs and Investment Act
  • H.R. 2423
    Unfair Tax Prevention Act
  • S. 864
    HELP Copays Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem